Book Value per Share: Sera Prognostics, Inc. (SERA)

Sera Prognostics is expanding its medical presence through partnerships with clinics and insurers to improve prenatal care. The historical price action, with a current value of 1.50, clearly demonstrates the asset's market volatility. Physicians value Sera Prognostics for its advanced diagnostics regarding preterm birth risks. Stable demand for medical innovations makes this business independent of global crises and a reliable asset.

Accounting Value of a Share: seraprognostics.com (SERA) for 07/04/2022 - 10/26/2026

seraprognostics.com - analytical breakdowns and key metrics (SERA)

- price and consensus price forecast:

Price Chart Sera Prognostics|SERA - Fair Value Consensus

- market capitalization data:

Market Capitalization Sera Prognostics, Inc.|SERA - Enterprise Value

- book capitalization data:

Net Assets per Single Share Sera Prognostics|SERA - Accounting Value of Company|Market Capitalization to Book Value Ratio seraprognostics.com|SERA - Company Assets

- debt and liquidity data:

Debt to Equity Sera Prognostics|SERA - Long-Term Liabilities to Equity|Short-Term Debt to Equity Sera Prognostics, Inc.|SERA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Sera Prognostics, Inc.

Fundamental company valuation: Sera Prognostics, SERA

Core merchandise of Sera Prognostics, Inc.

Book value per share reflects the dynamics of net assets, determining the actual asset value of each security by subtracting liabilities from total equity. For Sera Prognostics (SERA), the growth in aggregate book value per share confirms the effectiveness of investments in precision biosample logistics, where the optimization of courier networks directly converts into a strengthened fundamental base and business capitalization.

Competitors of Sera Prognostics (SERA)

Net Assets per Single Share Natera Corp (NTRA)|HUMA - Accounting Value of a Share